[go: up one dir, main page]

NO20092764L - Isosorbid mononitrat derivater for behandling av okular hypertensjon - Google Patents

Isosorbid mononitrat derivater for behandling av okular hypertensjon

Info

Publication number
NO20092764L
NO20092764L NO20092764A NO20092764A NO20092764L NO 20092764 L NO20092764 L NO 20092764L NO 20092764 A NO20092764 A NO 20092764A NO 20092764 A NO20092764 A NO 20092764A NO 20092764 L NO20092764 L NO 20092764L
Authority
NO
Norway
Prior art keywords
treatment
ocular hypertension
isosorbide mononitrate
mononitrate derivatives
derivatives
Prior art date
Application number
NO20092764A
Other languages
English (en)
Inventor
Jose Repolles Moliner
Francisco Pubill Coy
Marisabel Mourelle Mancini
Original Assignee
L Cer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38043051&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20092764(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by L Cer Sa filed Critical L Cer Sa
Publication of NO20092764L publication Critical patent/NO20092764L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Foreliggende oppfinnelse vedrører anvendelsen av en sammensetning med formel (I) eller en tautomer, et farmasøytisk akseptabelt salt, et prodrug eller en oppløsning derav: som aktiv(e) ingrediens(er) i fremstillingen av en farmasøytisk sammensetning for forebygging og/eller behandling av oftalmologiske sykdommer mediert av okular hypertensjon.
NO20092764A 2006-12-28 2009-07-27 Isosorbid mononitrat derivater for behandling av okular hypertensjon NO20092764L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06380338A EP1941876A1 (en) 2006-12-28 2006-12-28 Isosorbide mononitrate derivatives for the treatment of Inflammation and ocular hypertension
PCT/EP2007/064570 WO2008080939A1 (en) 2006-12-28 2007-12-27 Isosorbide mononitrate derivatives for the treatment of ocular hypertension

Publications (1)

Publication Number Publication Date
NO20092764L true NO20092764L (no) 2009-07-27

Family

ID=38043051

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20092763A NO20092763L (no) 2006-12-28 2009-07-27 Isosorbid mononitrat derivater for behandling av tarmlidelser
NO20092764A NO20092764L (no) 2006-12-28 2009-07-27 Isosorbid mononitrat derivater for behandling av okular hypertensjon

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20092763A NO20092763L (no) 2006-12-28 2009-07-27 Isosorbid mononitrat derivater for behandling av tarmlidelser

Country Status (21)

Country Link
US (1) US20080161389A1 (no)
EP (3) EP1941876A1 (no)
JP (2) JP2010514734A (no)
KR (2) KR20100100584A (no)
CN (2) CN101600425A (no)
AR (1) AR064543A1 (no)
AT (2) ATE484279T1 (no)
AU (2) AU2007341289B2 (no)
BR (2) BRPI0720663A2 (no)
CA (2) CA2674144A1 (no)
CL (2) CL2007003837A1 (no)
DE (2) DE602007007523D1 (no)
ES (3) ES2324130B1 (no)
IL (2) IL198912A0 (no)
MX (2) MX2009007038A (no)
NO (2) NO20092763L (no)
PL (2) PL2114398T3 (no)
RU (2) RU2009128970A (no)
UY (1) UY30847A1 (no)
WO (2) WO2008080939A1 (no)
ZA (2) ZA200903567B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2149577B1 (en) * 2008-07-22 2011-04-27 Lacer, S.A. New stereospecific method for the preparation of dioxa-bicyclooctane compounds
EP2149576A1 (en) * 2008-07-22 2010-02-03 Lacer, S.A. Isosorbide Nitrates having vasodilating activity
EP2177216A1 (en) * 2008-10-13 2010-04-21 Lacer, S.A. Use of dianhydrohexite mononitrate derivatives as healing agents
WO2010055138A1 (en) * 2008-11-14 2010-05-20 Lacer, S.A. New stereospecific method for the preparation of dioxa-bicyclooctane compounds
EP2199294A1 (en) * 2008-12-19 2010-06-23 Lacer, S.A. New stereospecific method for the preparation of dioxa bicyclooctane nitrate compounds
EP2515899B1 (en) * 2009-12-23 2016-05-25 ARCA biopharma, Inc. Methods and compositions for cardiovascular diseases and conditions
US20160016969A1 (en) * 2013-03-05 2016-01-21 Archer Daniels Midland Company Isohexide monotriflates and process for synthesis thereof
WO2018224419A1 (en) 2017-06-06 2018-12-13 Nicox S.A. Nitric oxide donating isomannide derivatives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2739689C2 (de) * 1977-09-02 1986-10-16 Euratom Thermische Wärmepumpe
JPS60149521A (ja) * 1984-01-18 1985-08-07 Eisai Co Ltd 高眼圧・緑内障治療・予防用点眼剤
US5573758A (en) * 1995-04-28 1996-11-12 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
US5925342A (en) * 1996-11-13 1999-07-20 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
GB9720797D0 (en) * 1997-09-30 1997-12-03 Rhodes John Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
ES2142773B1 (es) * 1998-10-07 2001-01-01 Lacer Sa Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida.
WO2002060449A2 (de) * 2001-01-31 2002-08-08 Merck Patent Gmbh Pharmazeutische formulierung enthaltend pyrazolo[4,3-d]pyrimidine und nitrate oder thienopyrimidine und nitrate
JP2005526092A (ja) * 2002-03-21 2005-09-02 ケイマン ケミカル カムパニー 緑内障および眼圧亢進を治療するためのプロスタグランジンＦ２α類縁体およびそれらの抗菌タンパク質との併用法
JP2007504807A (ja) * 2003-09-08 2007-03-08 ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム 培養培地にプロスタグランジン又はプロスタグランジン類似物を補足することによってインビトロ胚発生を高めるための方法及び組成
ES2258365B1 (es) * 2003-10-03 2007-12-01 Lacer, S.A. Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos.

Also Published As

Publication number Publication date
DE602007007523D1 (de) 2010-08-12
BRPI0720663A2 (pt) 2014-01-14
DE602007009877D1 (de) 2010-11-25
RU2009128968A (ru) 2011-02-10
ES2354317T3 (es) 2011-03-14
CA2674550A1 (en) 2008-07-10
CN101600425A (zh) 2009-12-09
EP2114398B1 (en) 2010-06-30
AR064543A1 (es) 2009-04-08
EP1941876A1 (en) 2008-07-09
AU2007341218A1 (en) 2008-07-10
AU2007341218B2 (en) 2010-09-09
WO2008080955A1 (en) 2008-07-10
ATE472324T1 (de) 2010-07-15
ATE484279T1 (de) 2010-10-15
KR20090112673A (ko) 2009-10-28
KR20100100584A (ko) 2010-09-15
MX2009007038A (es) 2009-08-25
EP2114398A1 (en) 2009-11-11
ES2324130B1 (es) 2010-03-22
ES2324130A1 (es) 2009-07-30
BRPI0720664A2 (pt) 2014-01-14
ZA200903567B (en) 2010-08-25
EP2124930B1 (en) 2010-10-13
PL2124930T3 (pl) 2011-04-29
IL198941A0 (en) 2010-02-17
PL2114398T3 (pl) 2010-11-30
JP2010514734A (ja) 2010-05-06
AU2007341289B2 (en) 2010-08-26
CL2007003836A1 (es) 2008-07-11
AU2007341289A1 (en) 2008-07-10
CN101600426A (zh) 2009-12-09
US20080161389A1 (en) 2008-07-03
JP2010514733A (ja) 2010-05-06
IL198912A0 (en) 2010-02-17
UY30847A1 (es) 2008-05-31
ZA200903566B (en) 2010-08-25
CL2007003837A1 (es) 2008-07-11
CA2674144A1 (en) 2008-07-10
MX2009007040A (es) 2009-08-25
EP2124930A1 (en) 2009-12-02
ES2348314T3 (es) 2010-12-02
WO2008080939A1 (en) 2008-07-10
RU2009128970A (ru) 2011-02-10
CN101600426B (zh) 2012-07-25
NO20092763L (no) 2009-07-27

Similar Documents

Publication Publication Date Title
NO20092764L (no) Isosorbid mononitrat derivater for behandling av okular hypertensjon
NO20082643L (no) Isokinolinaminopyrazolderivater, deres fremstilling og anvendelse som farmasoytiske midler for behandling av kreft
NO20074620L (no) Spiroheterocykliske forbindelser og deres anvendelse som medikamenter
SG170101A1 (en) 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
NO20071246L (no) Kinazolinonderivater og deres anvendelse som B-RAF-inhibitorer.
ATE517882T1 (de) Chinolinderivate
NO20074619L (no) Spiro-oksindolforbindelser og deres anvendelse som medikamenter
TW200621762A (en) Novel compounds
NO20084049L (no) Forbindelser med forsterket ampa receptor og anvendelse derav i medisin
MX2008013836A (es) Derivados de 2-piridona para el tratamiento de enfermedades o condiciones en las cuales es benefica la inhibicion de la actividad de elastasa de neutrofilos.
BR112015029491A2 (pt) derivados de imidazopirrolidinona e seu uso no tratamento de doença
NO20081844L (no) Terapeutiske forbindelser
NO20074703L (no) Antibakterielle piperidinderivater
WO2012142093A3 (en) 2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
WO2008054454A3 (en) Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents
NO20074781L (no) 4-Oksokinazolin-3-ylbenzamidderivater for behandling av cytokinsykdommer
WO2008046087A3 (en) Spiro compounds and their uses as therapeutic agents
EA200901423A1 (ru) Бензимидазолы и содержащие их фармацевтические композиции
EA201070483A1 (ru) Новые офтальмологические композиции
WO2021168483A3 (en) Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors
EA200971086A1 (ru) Фармацевтические композиции и способ лечения шизофрении
ATE529417T1 (de) 3',4',5-trimethoxyflavonderivate als die schleimsekretion stimulierendes mittel, entsprechendes verfahren und pharmazeutische zusammensetzung, die diese enthält
EP4442321A3 (en) Methods of treating sjögren's syndrome using a bruton's tyrosine kinase inhibitor
EA200701324A1 (ru) Соединения пиридина для лечения заболеваний, опосредованных действием простагландина
WO2007064448A3 (en) Cancer treatment using fts and 2-deoxyglucose

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application